Completed
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
NCT02087943
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
- Locations
-
- Arizona Research Center Phoenix, Arizona, United States
- Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield, California, United States
- Dermatology Research Associates Los Angeles, California, United States
- Renstar Medical Research Ocala, Florida, United States